Lupin LimitedNSE: LUPIN

Press Release Jun 17 2021

· Issued by Lupin Limited

Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated Jun 17, 2021, titled "Lupin Receives U.S. FDA Approval for Sevelamer Hydrochloride Tablets".

View Attachment

6ix hasn’t read this filing yet.

Lupin Limited on 6ix

Earlier from Lupin

Later from Lupin

All Lupin news releases